268 related articles for article (PubMed ID: 31138758)
1. Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.
Ding J; Sun D; Xie P
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138758
[No Abstract] [Full Text] [Related]
2. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells.
Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW
Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957
[TBL] [Abstract][Full Text] [Related]
4. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
Wang Y; Jiang Y; Chen L
J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
[TBL] [Abstract][Full Text] [Related]
5. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
Wang K; Jin J; Ma T; Zhai H
Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
7. Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis.
Li M; Yu D; Li Z; Zhao C; Su C; Ning J
Oncol Rep; 2021 Mar; 45(3):1094-1104. PubMed ID: 33650645
[TBL] [Abstract][Full Text] [Related]
8. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway.
Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H
Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
[TBL] [Abstract][Full Text] [Related]
11. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3.
Feng X; Luo Q; Wang H; Zhang H; Chen F
J Cell Physiol; 2018 Sep; 233(9):6705-6713. PubMed ID: 29319163
[TBL] [Abstract][Full Text] [Related]
13. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
Wang L; Liu H
Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
[TBL] [Abstract][Full Text] [Related]
14. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
Zhu R; Mao Y; Xu X; Li Y; Zheng J
Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
[TBL] [Abstract][Full Text] [Related]
15. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
[TBL] [Abstract][Full Text] [Related]
16. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
17. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
19. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
Mao Y; Zhang W; Zhang R; Zuo J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
[TBL] [Abstract][Full Text] [Related]
20. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.
Luo C; Zhang J; Zhang Y; Zhang X; Chen Y; Fan W
Cell Cycle; 2020 Aug; 19(15):1983-1993. PubMed ID: 32594835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
